{
  "ticker": "AVTX",
  "success": true,
  "price": {
    "current": 15.04,
    "currency": "USD",
    "day_high": 15.33,
    "day_low": 14.82,
    "52_week_high": 20.72,
    "52_week_low": 3.39
  },
  "market_cap": {
    "value": 278431840.0,
    "currency": "USD"
  },
  "shares_outstanding": 18512757.0,
  "volume": {
    "last": 59371,
    "average_30d": 298857
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -3.3044558,
    "price_to_book": 2.928919
  },
  "company_info": {
    "name": "Avalo Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T12:46:39.705716",
    "url": "https://finance.yahoo.com/quote/AVTX",
    "data_hash": "3801adbbae786b92"
  }
}